Login
News
07.02.2019 Planned Downtime MedCODES 22.-25. February
Our EDC MedCODES will be unavailable Feb 22nd until 25th.
Mehr ...04.02.2019 ESMO Breast Cancer 2019
ESMO Breast Cancer is an annual congress taking place on 2-4 May 2019 in Berlin, Germany.
Mehr ...18.01.2019 Prof. Loibl among highly cited researchers 2018
Prof. Dr. Sibylle Loibl, CEO of the GBG Forschungs GmbH and Professor at the Goethe University Frankfurt is featured among these researchers in 2018 for her work in breast cancer research.
Mehr ...17.12.2018 Results of an interim analysis from KATHERINE trial
We are delighted to inform you that the results of an interim analysis from KATHERINE, a phase III open-labeled trial, have been published in the New England Journal of Medicine.
Mehr ...30.11.2018 November 2018: Exploratory analysis on obese breast cancer patients from the PANTHER trial
Further results from the prospective PANTHER trial focused on obese breast cancer patients treated with adjuvant tailored dose-dense chemotherapy versus standard treatment has been published in the Annals of Oncology.
Mehr ...
GBG Forschungs GmbH
Martin-Behaim-Str. 12 | 63263 Neu-Isenburg | Fax +49 6102 7480-440